Fertility preservation paths for endometriosis patients

The answer depends on several things, including age, ovarian reserve, whether one or both ovaries are involved, and whether surgery is being considered. There is no single timetable that applies to every patient, but the question is worth discussing before an operation, when possible.

Fertility preservation has become a more visible part of endometriosis care because both the disease and ovarian surgery may affect ovarian reserve. The 2022 update of the European Society of Human Reproduction and Embryology (ESHRE) guideline recommends discussing the advantages and disadvantages of fertility preservation with women who have extensive ovarian endometriosis. The 2014 guideline had already raised this discussion, so the update did not introduce it for the first time. The continuing emphasis matters: a conversation about future fertility should not be postponed until after a procedure has reduced the options available.

Fertility preservation is one way to protect future choices. It cannot promise a pregnancy, and its usefulness depends on the person and the timing.

The intersection of endometriosis and ovarian reserve

An endometrioma is an ovarian cyst associated with endometriosis. It contains old blood and is embedded in or closely associated with ovarian tissue. That tissue contains follicles, including the small follicles that may later mature and release eggs. Endometriosis can involve the ovary and the surrounding environment in ways that may affect ovarian function. Inflammation, pressure from the cyst, and changes to nearby tissue are among the proposed contributors to follicle loss.

The relationship between an endometrioma and egg quality is not simple. The presence of a cyst does not tell us, on its own, how many eggs a person has or whether a future egg will form a healthy embryo. Research has found differences in ovarian reserve and treatment outcomes among some patients with endometriosis, but results vary. Age, disease extent, previous operations, and the way a study defines its comparison group all affect what can be concluded. A scan is part of the picture, not a fertility forecast.

Two commonly used measures help clinicians estimate ovarian reserve. Antral follicle count is the number of small follicles visible on ultrasound, usually assessed early in the menstrual cycle. Anti-Müllerian hormone, or AMH, is measured in blood and provides an indirect estimate of the remaining pool of recruitable follicles. Neither measure counts every egg, measures egg quality, or predicts with certainty whether a person will conceive without assistance. They are most useful when interpreted alongside age, medical history, ultrasound findings, and the patient’s goals.

The Bologna criteria for poor ovarian response include AMH below 0.5 ng/ml as one possible indicator, in combination with other factors. That figure is not a universal boundary between fertility and infertility, and it is not an endometriosis-specific threshold for deciding whether to freeze eggs. A clinician may pay more attention to a low result, a change over time, or a difference between the ovaries, but a single test should not carry the whole decision.

Endometriosis is common among people of reproductive age and is also seen frequently in fertility care. Those broad patterns explain why reproductive planning belongs in conversations about the disease. They do not mean that every person with endometriosis will need IVF, will have difficulty conceiving, or should pursue fertility preservation. Individual risk is shaped by the particular clinical picture.

Clinical indicators for proactive fertility preservation

A fertility consultation may be useful when a patient wants children in the future, is unsure about timing, or is facing treatment that could affect ovarian tissue. The purpose is not to prescribe egg freezing automatically. It is to clarify what is known about reserve, what is uncertain, and how the possible benefits and burdens of preservation fit the person’s plans.

Several features can make an early discussion especially relevant:

• Endometriomas in both ovaries. Bilateral disease can leave fewer unaffected areas of ovarian tissue than a cyst on one side. The actual reserve still needs to be assessed; the scan alone cannot show exactly how many eggs are available.
• A cyst that is large, growing, painful, or being considered for surgery. Size can be one clinical consideration, particularly when it affects symptoms or the surgical plan. A 3 cm cyst is not an ESHRE cutoff for fertility preservation, and size by itself does not determine whether egg freezing is appropriate.
• A recurrent endometrioma after previous ovarian surgery. A repeat operation deserves careful discussion because ovarian tissue may be affected by both the disease and prior treatment.
• AMH or antral follicle count that is low for age, or a concerning change over time. Results should be interpreted in context, including how and when they were measured.
• Age and personal reproductive timeline. Age is relevant to egg number and egg quality, but it does not replace an assessment of the individual’s reserve, health, and preferences.
• A planned treatment that may delay attempts at pregnancy. Pain management, surgery, and reproductive goals can pull in different directions. A coordinated plan helps make those trade-offs explicit.

The same ultrasound finding can lead to different conversations. A patient with a unilateral endometrioma, stable reserve measures, and plans to try for pregnancy soon may have different priorities from someone with bilateral disease, previous ovarian surgery, and no immediate plans for children. In both cases, the question is how the available information relates to the patient’s own timeline, not whether a cyst automatically triggers a procedure.

Counseling should also include the limits of testing. AMH and follicle count can help estimate how the ovaries may respond to stimulation; they cannot guarantee the number of eggs retrieved, the number that will be suitable to freeze, or the chance of a future live birth. Fertility preservation can offer an option, but it does not remove the effects of age or endometriosis, and it may require more than one treatment cycle.

Navigating the oocyte cryopreservation process

Mature oocyte cryopreservation, commonly called egg freezing, is an established option for many patients who want to preserve eggs without deciding now whose sperm will be used. Embryo cryopreservation follows a similar stimulation and retrieval process, but the eggs are fertilized before freezing. That may suit someone who is ready to use a partner’s sperm or donor sperm, while egg freezing leaves that decision for later.

A cycle usually takes a few weeks from the start of ovarian stimulation to egg retrieval. The exact schedule and medication plan depend on the patient’s response, the clinic, and any medical considerations related to the endometrioma. The usual sequence is:

1. Initial assessment. The team reviews medical and surgical history, ultrasound findings, AMH and other relevant blood tests, and the patient’s goals. The assessment helps estimate how the ovaries may respond and whether the cyst affects access to follicles.

2. Ovarian stimulation. Daily injectable medicines encourage several follicles to grow during one cycle. Medication and dose are tailored to the patient. The aim is to recruit a group of follicles, rather than the single dominant follicle typical of an unstimulated cycle.

3. Monitoring. Ultrasound examinations and, when appropriate, blood tests track follicle development and guide medication adjustments. Monitoring continues until the follicles are ready for the next step.

4. Final maturation and retrieval. A trigger medication is given at a specific time before retrieval. The eggs are collected through a needle guided by ultrasound, usually with sedation. The procedure and the route used are discussed in advance, including any concerns about the cyst.

5. Assessment and freezing. A laboratory team identifies the eggs and freezes those that are mature using vitrification, a rapid-freezing method. The patient is told how many mature eggs were stored and what that result does, and does not, suggest about future chances.

For patients with endometriomas, one practical concern is that a stimulation cycle may yield fewer eggs than expected. Studies have reported lower average oocyte yields in some groups with endometriomas compared with comparison groups, but an average cannot predict the outcome for one person. The result depends on age, reserve, the number of follicles recruited, and other clinical factors. A second cycle may be discussed if the first produces fewer eggs than hoped, but that decision has to account for cost, time, symptoms, and the patient’s preferences.

Egg freezing also involves more than the retrieval itself. Stimulation can bring temporary side effects, and the patient needs to understand the medication schedule, monitoring visits, procedure, storage arrangements, and costs. The potential benefit is the chance to use frozen eggs in the future; the limitation is that freezing does not ensure they will later produce a pregnancy. A useful consultation makes room for both parts of that discussion.

Surgical considerations and the risk of iatrogenic damage

Surgery may relieve pain, improve access to the ovaries for fertility treatment, or address a cyst whose appearance or behaviour needs investigation. It can also affect ovarian tissue. During a cystectomy, the surgeon separates the cyst wall from the ovary. The boundary between the cyst and healthy tissue is not always clear, and some normal ovarian tissue or follicles may be removed or damaged. Bleeding control and other aspects of the procedure can also influence the amount of injury.

Studies generally show that ovarian reserve measures can decline after endometrioma surgery, though the size and duration of the change vary. Cyst features, whether one or both ovaries are operated on, the surgical technique, and the surgeon’s experience all matter. AMH may be measured before and after surgery, but changes in the result do not give a complete account of future fertility. The possibility of reserve loss is one reason to discuss preservation before an operation when it is relevant to the patient’s plans.

That discussion is not an argument against surgery when surgery is indicated. Persistent pain, concerning imaging features, or other clinical reasons may make an operation the right choice. The question is whether fertility goals can be considered in the same plan. For some patients, egg or embryo freezing before surgery may be worth exploring. For others, it may not be feasible, may not be a priority, or may not offer enough expected benefit to justify the burden. The sequence should be decided with the treating gynaecologist and fertility specialist, not assumed in advance.

Surgery can also complicate later fertility treatment. A cyst may affect how easily follicles can be reached during egg retrieval, while operating on the cyst may reduce reserve. Clinicians weigh these competing concerns rather than treating either surgery or egg freezing as an automatic first step. The balance may differ between someone with substantial pain and someone whose cyst is being monitored without symptoms.

Pre-treatment medication is another area where broad rules can mislead. Hormonal treatment may be used to manage endometriosis symptoms, but it does not remove the need for an individual fertility plan. The 2022 ESHRE guideline does not support routine extended pretreatment with GnRH agonists before assisted reproduction as a blanket approach. Decisions about medication depend on the reason for treatment, symptoms, timing, and the planned fertility intervention.

Before an ovarian operation, it is reasonable to ask how the procedure may affect reserve and whether a fertility consultation could change the timing or plan.

Experimental frontiers: ovarian tissue cryopreservation

Ovarian tissue cryopreservation involves removing and freezing tissue from the outer part of the ovary, where many early-stage follicles are found. Unlike egg or embryo freezing, it does not require stimulation before the tissue is collected. The tissue may later be transplanted back into the body, with the aim of restoring ovarian function and, in some cases, allowing pregnancy. The method is used in selected fertility-preservation settings, particularly when a person cannot wait for a stimulation cycle before treatment that may damage the ovaries.

For endometriosis, ovarian tissue cryopreservation remains a limited and specialist option rather than routine care. The evidence base for its use in this population is much less developed than for egg or embryo freezing. There are practical and clinical questions about which patients might benefit, how much usable tissue can be collected, and whether transplanting tissue could create problems related to endometriosis. These concerns require specialist assessment; they cannot be resolved by treating the technique as equivalent to standard egg freezing.

A clinician may raise the option when conventional egg or embryo freezing is not feasible, or when a specialist centre is evaluating it within a research protocol. For most patients with endometriosis, the first discussion is more likely to focus on ovarian reserve, surgery, and whether oocyte or embryo cryopreservation fits their circumstances. If ovarian tissue preservation is mentioned, patients should ask what evidence applies to their situation and whether the proposed approach is established care or part of research.

Where the conversation belongs

Fertility counseling for reproductive-age women with endometriosis is most useful when it happens early enough to inform decisions. That does not mean everyone needs to freeze eggs as soon as a diagnosis is made. It means that future family-building plans, current symptoms, ovarian reserve, and possible surgery should be discussed together rather than in separate appointments that never quite meet.

The decision may change as symptoms, test results, and personal plans change. Someone who is uncertain about children still deserves clear information, without pressure to choose a path immediately. Someone planning pregnancy soon may prioritize pain management or attempts to conceive rather than preservation. And for someone considering surgery, learning about fertility options beforehand may help clarify the trade-offs, even if the eventual choice is to proceed without freezing eggs.

A practical next step is to ask the care team how age, AMH, antral follicle count, cyst location and size, and surgical history fit together in this particular case. Ask what egg freezing could reasonably offer, what it would involve, and whether delaying or changing the order of treatment is medically appropriate. The aim is not to make every decision now. It is to make decisions with a clear view of the options, before a treatment sequence closes off choices that matter to you.